PUBLICATIONS | PRESS RELEASES | < BACK
Press Releases
XX/XX/2009
Calixa Therapeutics Announces Promising Phase 1 Results for CXA-101,
A Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-pseudomonal Activity
PUBLICATIONS | PRESS RELEASES | < BACK
XX/XX/2009
Calixa Therapeutics Announces Promising Phase 1 Results for CXA-101,
A Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-pseudomonal Activity